FDA Aims To Invigorate Sluggish Drug-Labeling Overhaul

Law360, New York (February 5, 2013, 6:22 PM EST) -- Citing disappointing progress on improved prescription-drug labeling, the U.S. Food and Drug Administration said Tuesday that it was looking at providing the pharmaceutical industry with assistance to update drugs' safety information.

The agency is responding to a requirement that all new drugs approved after June 30, 2001, comply with new standards intended to make labels easier to read and more focused on the most important warnings about a drug’s risks. Despite that rule, as well as efforts to encourage voluntary labeling updates for older drugs, only...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.